title: Panitumumab rechallenge in chemorefractory patients with metastatic colorectal cancer.
authors.affiliation: Division of Integrated Oncology, Institute of Biomedical Research and Innovation, 2-2, Minatojima-minamimachi, Chuo-ku, Kobe, 650-0047, Japan, akitohata@hotmail.com.
authors.forename: Akito
authors.initials: A
authors.lastname: Hata
authors.forename: Nobuyuki
authors.initials: N
authors.lastname: Katakami
authors.forename: Shiro
authors.initials: S
authors.lastname: Fujita
authors.forename: Kento
authors.initials: K
authors.lastname: Takatori
authors.forename: Aya
authors.initials: A
authors.lastname: Horai
authors.forename: Naoto
authors.initials: N
authors.lastname: Kitajima
authors.forename: Kazuki
authors.initials: K
authors.lastname: Terashima
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D019008:Drug Resistance, Neoplasm / Q000187:drug effects*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008297:Male; D008875:Middle Aged; D000077544:Panitumumab; D011379:Prognosis; D016879:Salvage Therapy; D014057:Tomography, X-Ray Computed
chemical_list: D000911:Antibodies, Monoclonal; D000077544:Panitumumab; D066246:ErbB Receptors